The metrics — click any for its citations + threads

Posture med

expanding 5 src →

Capital · available med

~$183-242M cumulative raised across 5 disclosed rounds (Convertible Note $535K 2017, Seed $2.5M 2018, Series A $3M 2019, Series B $27M 2020, Series C $150M Jul-2021); GetLatka sums the … 6 src →

Capital · operating low

no official revenue disclosed. Third-party estimator outputs disagree by ~8x: $20M (Zippia), $59.9M (RocketReach), $159M (Compworth, 2026), $10-100M range (IncFact) — none are … 6 src →

Capital · deployed med

capital deployed into nationwide network buildout (all 50 states therapy Apr-2025, nationwide psychiatry Nov-2025) and three tuck-in acquisitions (Qntfy ML platform Oct-2021, Total Brain … 5 src →

Capital · in med

VC equity rounds only (General Catalyst led Series B; Series C investor syndicate not individually confirmed in sources reached) plus payer-contract/insurance-reimbursement revenue as the … 2 src →

Capital · out low

operating spend across a ~50-state clinician network (~12,500 licensed providers) and R&D (AI-assisted matching/practice tools, the Jul-2026 guardrails release); no disclosed multi-year … 2 src →

Optionality med

constrained — VC-backed private company (General Catalyst and other undisclosed Series C investors), board oversight, no public listing. Jan-2024 layoffs (~17% of staff) and no fresh primary … 4 src →

Gravity low

~$0.1-0.15B/yr (estimate, low confidence) — reasoned in patients-in-care / payer-contract-revenue terms per the wave recipe, not gross provider/user counts. SonderMind is an in-network … 6 src →